Service Hotline: +86 4006196063
Integrate global high-quality resources and technologies to better meet the scientific diagnosis demands over the whole life quality cycle,
and provide abundant, advanced, convenient and accessible products and solutions for diagnostic and treatment institutions,
families and individuals in the world by virtue of constant scientific and technological innovation and iteration.
Fosun Diagnostics Technology (Shanghai) Co., Ltd. was founded in 1989.
Fosun Diagnotics always upholds the mission of "integrating innovative diagnostic techniques and safeguarding lives and health of the world".
Focusing on the IVD industry, it promotes the development and implementation of innovative technologies and products and is committed to becoming a world-leading scientific and technological innovator in the field of comprehensive solutions for medical diagnosis.
Learn news and brand events of the company from the latest information of Fosun Diagnostics,
and explore the healthy and ecological development trend in the diagnostic field.
May
SBC Biomedlab of Fosun Diagnostics responded to the demand for normalized nucleic acid sampling in the first time and set the first Biomedlab sampling booth in the south of Shanghai North High-tech Park (at the intersection of Jiangchang 3rd Road and Wenshui Road). Subsequently, several nucleic acid sampling booths will be successively set in other areas of Shanghai to help citizens get a nucleic acid test upon arrival.
May
On April 20, the first batch of COVID-19 antigen test kits (for 100,000 tests) arrived at Fudan University to support epidemic prevention and control in Shanghai, which was donated by Wisdomshire Asset Management Co., Ltd., Shanghai Ningquan Asset Management Co., Ltd., Fosun Foundation and Fosun Diagnostics.
May
With the deepening of the medical reform process in China and the continuous improvement of public health awareness, the demand for medical services continues to grow rapidly. The implementation of the national three-child policy, the increasingly serious aging of the population and the increase in the incidence of chronic diseases and diseases also put forward higher requirements for clinical diagnosis and treatment.
May
Recently, the Ministry of Industry and Information Technology of the PRC, National Health Commission of the PRC, National Development and Reform Commission, Ministry of Science and Technology of the PRC, Ministry of Finance of the PRC, State-owned Assets Supervision and Administration Commission of the State Council, State Administration for Market Regulation, National Healthcare Security Administration, National Administration of Traditional Chinese Medicine, and National Medical Products Administration jointly issued the Development Plan for the Medical Equipment Sector during the "14th Five-Year Plan" Period (hereinafter referred to as the Plan).Testing and diagnostic medical devices have been listed as the key development area in the Plan with a focus on POCT.
Adhering to the brand concept of "diagnostic technology within reach",
Fosun Diagnostics pursues sustainable development, actively practices corporate social responsibilities,
and safeguards the health of more people in a responsible manner.
Shanghai ICP Filing No.06018982-5
COPYRIGHT @2019-2022 Fosun Diagnostics (Shanghai) Co., Ltd.
Shanghai PSB Filing No.11010808888
No. of Qualification Certificate for Medicine Trading Services on the Internet:
(Shanghai)-Non-operating-2018-0046
